JP2019529482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529482A5 JP2019529482A5 JP2019516976A JP2019516976A JP2019529482A5 JP 2019529482 A5 JP2019529482 A5 JP 2019529482A5 JP 2019516976 A JP2019516976 A JP 2019516976A JP 2019516976 A JP2019516976 A JP 2019516976A JP 2019529482 A5 JP2019529482 A5 JP 2019529482A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- keto
- hydroxytyrosol
- acetyl
- boswellic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 17
- HMMGKOVEOFBCAU-BCDBGHSCSA-N 3-Acetyl-11-keto-beta-boswellic acid Chemical compound C1C[C@@H](OC(C)=O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC(=O)[C@@H]3[C@]21C HMMGKOVEOFBCAU-BCDBGHSCSA-N 0.000 claims 9
- HMMGKOVEOFBCAU-UHFFFAOYSA-N AKBA Natural products C1CC(OC(C)=O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CC(=O)C3C21C HMMGKOVEOFBCAU-UHFFFAOYSA-N 0.000 claims 9
- 229940095066 hydroxytyrosol Drugs 0.000 claims 9
- 235000003248 hydroxytyrosol Nutrition 0.000 claims 9
- 241001465754 Metazoa Species 0.000 claims 4
- 230000037396 body weight Effects 0.000 claims 4
- 241000282472 Canis lupus familiaris Species 0.000 claims 3
- 240000007817 Olea europaea Species 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 235000002725 Olea europaea Nutrition 0.000 claims 2
- 210000002808 connective tissue Anatomy 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 240000007551 Boswellia serrata Species 0.000 claims 1
- 235000012035 Boswellia serrata Nutrition 0.000 claims 1
- 241000282832 Camelidae Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022082301A JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A JP7876938B2 (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2026095727A JP2026127783A (ja) | 2016-10-04 | 2026-06-08 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403807P | 2016-10-04 | 2016-10-04 | |
| US62/403,807 | 2016-10-04 | ||
| PCT/US2017/028857 WO2018067200A1 (en) | 2016-10-04 | 2017-04-21 | Compositions comprising hydroxytyrosol and boswellic acid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082301A Division JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529482A JP2019529482A (ja) | 2019-10-17 |
| JP2019529482A5 true JP2019529482A5 (enExample) | 2020-05-28 |
| JP7079551B2 JP7079551B2 (ja) | 2022-06-02 |
Family
ID=58664857
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516976A Active JP7079551B2 (ja) | 2016-10-04 | 2017-04-21 | ヒドロキシチロソールおよびボスウェリン酸を有する組成物 |
| JP2022082301A Active JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A Active JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A Active JP7876938B2 (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2026095727A Pending JP2026127783A (ja) | 2016-10-04 | 2026-06-08 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082301A Active JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A Active JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A Active JP7876938B2 (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2026095727A Pending JP2026127783A (ja) | 2016-10-04 | 2026-06-08 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US10342802B2 (enExample) |
| EP (2) | EP4623994A3 (enExample) |
| JP (5) | JP7079551B2 (enExample) |
| CN (2) | CN120241745A (enExample) |
| AU (3) | AU2017340126B2 (enExample) |
| CA (1) | CA3039233A1 (enExample) |
| ES (1) | ES3040765T3 (enExample) |
| PL (1) | PL3522874T3 (enExample) |
| WO (1) | WO2018067200A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3039233A1 (en) | 2016-10-04 | 2018-04-12 | Nutramax Laboratories, Inc. | Compositions comprising hydroxytyrosol and boswellic acid |
| CN115282154A (zh) * | 2022-08-15 | 2022-11-04 | 武汉科前生物股份有限公司 | 11-羰基-β-乙酰乳香酸在制备治疗猫传腹药物中的用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358542B2 (en) | 1999-12-20 | 2002-03-19 | Usana, Inc. | Antioxidant compositions extracted from olives and olive by-products |
| US7713569B2 (en) | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| JP3820218B2 (ja) | 2000-09-01 | 2006-09-13 | クレアグリ， インコーポレイテッド | 植物水からヒドロキシチロソール富化組成物を得る方法 |
| WO2003068171A2 (en) | 2002-02-13 | 2003-08-21 | Creagri, Inc. | Method and composition for treatment of inflammation and aids-associated neurological disorders |
| WO2003077860A2 (en) * | 2002-03-13 | 2003-09-25 | Biophysica, Inc. | BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES |
| EP1582512A1 (en) | 2004-03-31 | 2005-10-05 | Cognis IP Management GmbH | Process for obtaining hydroxytyrosol from olive leaves extracts |
| US7625947B2 (en) | 2004-06-18 | 2009-12-01 | Laila Nutraceuticals | Analogs of 3-O-acetyl-11-keto-β-boswellic acid |
| JP2008509224A (ja) * | 2004-08-09 | 2008-03-27 | クレアグリ， インコーポレイテッド | 炎症状態を治療するためのオリーブ組成物及び方法 |
| CN101516364B (zh) * | 2006-07-14 | 2011-12-28 | 帝斯曼知识产权资产管理有限公司 | 组合物及其用于治疗、共治疗或预防炎性病症的用途 |
| WO2008006582A1 (en) * | 2006-07-14 | 2008-01-17 | Dsm Ip Assets B.V. | Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| JP2008120716A (ja) | 2006-11-10 | 2008-05-29 | Eisai Food Chemical Kk | 抗炎症剤 |
| WO2010029578A2 (en) | 2008-09-15 | 2010-03-18 | Ganga Raju Gokaraju | Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
| CN102451428A (zh) * | 2010-10-14 | 2012-05-16 | 中国中医科学院广安门医院 | 可用于治疗类风湿关节炎的中药组合物 |
| US9144555B2 (en) * | 2012-11-30 | 2015-09-29 | Darlene E. McCord | Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition |
| CA3039233A1 (en) | 2016-10-04 | 2018-04-12 | Nutramax Laboratories, Inc. | Compositions comprising hydroxytyrosol and boswellic acid |
-
2017
- 2017-04-21 CA CA3039233A patent/CA3039233A1/en active Pending
- 2017-04-21 JP JP2019516976A patent/JP7079551B2/ja active Active
- 2017-04-21 AU AU2017340126A patent/AU2017340126B2/en active Active
- 2017-04-21 CN CN202510507272.9A patent/CN120241745A/zh active Pending
- 2017-04-21 CN CN201780061735.7A patent/CN109789110A/zh active Pending
- 2017-04-21 ES ES17720995T patent/ES3040765T3/es active Active
- 2017-04-21 PL PL17720995.4T patent/PL3522874T3/pl unknown
- 2017-04-21 EP EP25185237.2A patent/EP4623994A3/en active Pending
- 2017-04-21 EP EP17720995.4A patent/EP3522874B1/en active Active
- 2017-04-21 WO PCT/US2017/028857 patent/WO2018067200A1/en not_active Ceased
- 2017-04-21 US US15/494,022 patent/US10342802B2/en active Active
-
2019
- 2019-04-12 US US16/382,672 patent/US10722524B2/en active Active
-
2020
- 2020-03-26 US US16/830,454 patent/US11241444B2/en active Active
-
2021
- 2021-12-22 US US17/559,571 patent/US11980624B2/en active Active
-
2022
- 2022-05-19 JP JP2022082301A patent/JP7341596B2/ja active Active
-
2023
- 2023-05-31 AU AU2023203427A patent/AU2023203427B2/en active Active
- 2023-08-25 JP JP2023137408A patent/JP7562225B2/ja active Active
-
2024
- 2024-04-24 US US18/644,758 patent/US20240285648A1/en active Pending
- 2024-09-20 JP JP2024163552A patent/JP7876938B2/ja active Active
-
2025
- 2025-04-23 AU AU2025202875A patent/AU2025202875B2/en active Active
-
2026
- 2026-06-08 JP JP2026095727A patent/JP2026127783A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3721882T3 (fi) | Aineenvaihduntahäiriöiden hoito hevoseläimissä | |
| DOP2018000262A (es) | Uso de indazoles sustituidos para el tratamiento y la prevención de enfermedades en animales | |
| PH12019502241A1 (en) | Berberine alkaloids in the prevention and/or treatments of intestinal disease | |
| CY1122335T1 (el) | Μουσκαρινικοι ανταγωνιστες και συνδυασμοι τους για τη θεραπευτικη αντιμετωπιση της νοσου των αναπνευστικων οδων στα αλογα | |
| JP2017532369A5 (enExample) | ||
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| CL2014003119A1 (es) | Método de tratamiento no terapéutico de aves de corral, cerdos o peces para reducir la relación de conversión de alimento o incrementar su ganancia de peso corporal, que comprende la adminsitración oral de beta-alanina; y alimento para aves, cerdos o peces, que comprende beta-alanina como aditivo. | |
| IN2015DN02894A (enExample) | ||
| JP2023085448A (ja) | 乳酸菌により非ヒト動物の異常な感情又は行動を予防又は治療する方法 | |
| CN110022882A (zh) | 促进胃肠系统动力的复合维生素组合物 | |
| BR112019003890A2 (pt) | uso de oligossacarídeos de leite humano em engordamento de bezerros | |
| JP2017527591A5 (enExample) | ||
| MX2018010495A (es) | Nuevos productos inmunobiologicos. | |
| JP2016513738A5 (enExample) | ||
| GB2550750A (en) | Anthelmintic compounds | |
| JP2003012555A (ja) | 動伴侶動物における問題行動を防止するための医薬組成物および方法 | |
| JP6227594B2 (ja) | 動物の発毛促進用組成物及びその配合物 | |
| Hisham et al. | Physical and performance characteristics of Rajapalayam dogs of Tamil Nadu | |
| JP5830474B2 (ja) | 獣医学領域における炎症および疼痛の治療のための、中枢作用性鎮痛剤と選択的シクロオキシゲナーゼ−２阻害剤抗炎症薬との組み合わせ | |
| Kumar | Clinical management of bovine ulcerative mammilitis-a case report | |
| MX386932B (es) | Proceso para formulaciones sólidas de mesalazina. | |
| Andrea | Acupuncture treatment of pseudo-pregnancy in a female dog: a case report | |
| Du Pisanie | Scabby mouth: dangerous for man and animal | |
| Giri et al. | Diagnosis and therapeutic management of oestrosis in small ruminants | |
| Scott | House dust mites trigger asthma attacks through trickery |